FUJIFILM Holdings President and CEO Teiichi Goto Awarded the Medal of Friendship by the President of Mongolia

In Mongolia, cancer and lifestyle diseases such as ischemic heart disease are leading causes of death^*1. The number of patients dying or falling critically ill as a result of these diseases can be reduced through early disease detection followed by appropriate treatment and health guidance. However, health screening services in Mongolia are not as widely available as in Japan, which frequently makes it difficult to detect diseases in their early stages.

Fujifilm has been providing health screening services in the NURA centers in Ulaanbaatar, Mongolia in partnership with the Tavan Bogd Group. The first NURA health screening center opened in Mongolia on September, 2023, is equipped with Fujifilm's medical devices including CT scan and mammography system, as well as medical IT system based on AI technology designed to support doctors conduct screening and tests for cancer and lifestyle diseases. The service has been well received by users, with more than 15,000 people already using the service, thanks to the convenience of being able to complete all checks and receive feedback on the results in just about 120 minutes. Another point that has been highly acclaimed is that users are able to hear the results from a doctor while viewing the actual diagnostic images. On August 1, 2024, the second NURA health screening center opened. In order to make NURA health screening service accessible to more individuals, Fujifilm and the Tavan Bogd Group will expand the establishment of NURA centers in Mongolia.

Fujifilm will continue to provide high-quality services to an increasing number of people, thereby contributing to advancement of global health.

• *1 Source: "Global Health Estimates: Life expectancy and leading causes of death and disability" on WHO website.